Thousands of breast cancer patients could avoid gruelling chemotherapy thanks to research carried out by a Welsh surgeon.
Simon Holt, a breast surgeon at Hywel Dda Local Health Board, led a study into a new test to help determine whether a breast cancer patient needs to have the treatment.
The National Institute for Health and Care Excellence (NICE) has approved the 'Oncotype DX' test, which is used in people with certain types of genes and who are assessed as being at intermediate risk of their cancer spreading.
The test measures the presence of biological characteristics in the tumour which may show how likely it is to grow and whether it is likely to spread. Combined with other clinical information, the test will help determine which patients are most suitable for chemotherapy.
More top news
A final dig at the site of an early Medieval chapel on Pembrokeshire beach is expected to reveal more about the history of Wales.
Carwyn Jones speaks to our Political Editor Adrian Masters in the final part of our pre-election series on ITV Cymru Wales.
Alexandra Lodge has been to Aberconwy, where Plaid Cymru, the Conservatives and Labour are all hoping to claim victory.